or Try an Advanced Search...

    Technical Analysis for PTPI - Petros Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.55 6.67% 0.03
    PTPI closed down 12.31 percent on Wednesday, May 15, 2024, on 54 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical PTPI trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 6.67%
    Expansion Breakdown Bearish Swing Setup 6.67%
    New 52 Week Low Weakness 6.67%
    BB Squeeze Ended Range Expansion 6.67%
    Gapped Up Strength 6.67%
    Below Lower BB Weakness 6.67%
    Down 3 Days in a Row Weakness 6.67%
    Down 4 Days in a Row Weakness 6.67%
    Down 5 Days in a Row Weakness 6.67%
    Lower Bollinger Band Touch Weakness 6.67%
    Older End-of-Day Signals for PTPI ...

       Recent Intraday Alerts

    Alert Time
    Gapped Up (Partial) 31 minutes ago
    Rose Above Lower Bollinger Band 31 minutes ago
    Up 5% 31 minutes ago
    Up 3% 31 minutes ago
    Up 2% 31 minutes ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    PTPI Chart by TradingView
    Basic chart:

    Profile

    Petros is committed to becoming the world's leading men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to ED, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease (acute and chronic), hormone health and substance use disorders.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Disease Disorders Dysfunction Chronic Condition Petros Men's Health Psychosocial Substance Use Disorder

    Is PTPI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 3 Petros Pharmaceuticals files $100M mixed securities shelf
    Apr 25 Petros Pharmaceuticals announces online distribution for lead ED product with Lemonaid Health
    Apr 23 Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA(R) (avanafil) Through New Agreement with Lemonaid Health
    Apr 16 Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil)
    Apr 2 Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Apr 2 Petros Pharmaceuticals Reports Positive Results in an Initial Cohort Two-Arm Self-Selection (Phase 2-Equivalent) Study for STENDRA(R) (avanafil) as it Pursues OTC Status
    Mar 19 Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration with Multi-Billion-Dollar Software Provider
    Feb 14 Petros Pharmaceuticals Enters into AI Licensing Agreement with Leading Multi-Billion-Dollar Software Provider
    Jan 24 Petros Pharmaceuticals Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA(R) (avanafil) Rx-to-OTC Switch
    Jan 17 Petros Pharmaceuticals Demonstrates Positive Results Following Successful Completion of Initial Cohort of Phase 2 Equivalent Self-Selection Study for STENDRA (avanafil) Rx-to-OTC Switch
    See more PTPI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.74
    52 Week Low 0.5009
    Average Volume 563,832
    200-Day Moving Average 1.56
    50-Day Moving Average 1.01
    20-Day Moving Average 0.65
    10-Day Moving Average 0.64
    Average True Range 0.07
    RSI (14) 23.66
    ADX 23.29
    +DI 14.54
    -DI 30.57
    Chandelier Exit (Long, 3 ATRs) 0.68
    Chandelier Exit (Short, 3 ATRs) 0.72
    Upper Bollinger Bands 0.74
    Lower Bollinger Band 0.57
    Percent B (%b) -0.28
    BandWidth 26.86
    MACD Line -0.11
    MACD Signal Line -0.12
    MACD Histogram 0.0113
    Fundamentals Value
    Market Cap 1.13 Million
    Num Shares 2.2 Million
    EPS -6.21
    Price-to-Earnings (P/E) Ratio -0.08
    Price-to-Sales 0.44
    Price-to-Book 0.37
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.69
    Resistance 3 (R3) 0.71 0.66 0.66
    Resistance 2 (R2) 0.66 0.62 0.65 0.65
    Resistance 1 (R1) 0.59 0.59 0.57 0.57 0.64
    Pivot Point 0.54 0.54 0.53 0.54 0.54
    Support 1 (S1) 0.47 0.50 0.45 0.46 0.39
    Support 2 (S2) 0.43 0.47 0.42 0.38
    Support 3 (S3) 0.35 0.43 0.37
    Support 4 (S4) 0.34